Therapeutic inhibition of RIP1 improves metabolic dysfunction and inhibits atherosclerosis in mouse models of cardiometabolic diseasesDenuja Karunakaran, Katey J. Rayner, Joshua W. Kandiah et al.|The FASEB Journal|2018Cited by 1
Abstract 17409: Therapeutic Inhibition of RIP1 Improves Metabolic Dysfunction and Inhibits Atherosclerosis in Mouse Models of Cardiometabolic DiseasesDenuja Karunakaran, Katey J. Rayner, Michèle Geoffrion et al.|Circulation|2017Cited by 0